Legal & General Group PLC Xenon Pharmaceuticals Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 60,530 shares of XENE stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,530

Previous 60,530 -0.0%

Holding current value

$2.35 Million

Previous $2.38 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $200,100 - $241,500	5,520 Added 10.03%	60,530 $2.36 Million
Q1 2024 May 14, 2024	BUY	$42.66 - $50.04 $58,060 - $68,104	1,361 Added 2.54%	55,010 $2.37 Million
Q4 2023 Feb 15, 2024	BUY	$28.7 - $46.46 $256,463 - $415,166	8,936 Added 19.99%	53,649 $2.47 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $65,621 - $76,321	1,921 Added 4.49%	44,713 $1.53 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $163,155 - $203,897	-4,683 Reduced 9.86%	42,792 $1.65 Million
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $1.07 Million - $1.29 Million	31,947 Added 205.74%	47,475 $1.7 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $130,587 - $155,748	3,950 Added 34.12%	15,528 $612,000
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $9,390 - $12,145	305 Added 2.71%	11,578 $418,000
Q2 2022 Aug 22, 2022	BUY	$25.44 - $35.16 $12,770 - $17,650	502 Added 4.66%	11,273 $343,000
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $6,473 - $8,547	258 Added 2.45%	10,771 $330,000
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $58,734 - $133,281	3,765 Added 55.79%	10,513 $328,000
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $82,502 - $107,986	5,552 Added 464.21%	6,748 $103,000
Q2 2020 Aug 14, 2020	BUY	$10.21 - $14.9 $12,211 - $17,820	1,196 New	1,196 $15,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Xenon Pharmaceuticals Inc. Transaction History